All Episodes

Where Are We Now With Immunotherapy in Multiple Myeloma?

Menin Inhibitors to Treat Acute Myeloid Leukemia (AML)

How Experts Treat HIV-associated Lymphomas

Hematology Portraits: Associate Prof Meritxell Alberich Jordà

How Experts Treat Large B-cell Lymphoma (LBCL)

Connecting Hematology Research and Real Life: Peter Kapitein

How Experts Treat Peripheral T- and NK-cell Lymphomas

Hematology Portraits: Prof Konstanze Döhner

How Blood Cells Age: From Stem Cells to Clones (with Dr Michael Milsom)

How Experts Treat Mantle Cell Lymphoma (with Prof Mats Jerkeman)

Life After CAR T-cell Therapy: Jonathan Clark’s Journey with Mantle Cell Lymphoma and the Future of Patient Advocacy

The Role of Artificial Intelligence in Hematology (featuring Dr Gregor Hormann)

How Does Climate Change Affect Hematology Practice? (with Dr Stephen Hibbs)

Accelerating Clinical Trials with AI (with Dr Jan Moritz Middeke)

EHA Junior Research Grant: Dr Ana Río-Machín’s Journey in AML Research and Collaborative Science

Hematologists’ Role in the Management of Gaucher Disease (Prof Argiris Symeonidis and Prof Sam Salek)

Navigating the Toughest Challenges in Hematology Nursing: Insights from HNHCP Leaders

A Multiple Myeloma and MRD Pioneer: EHA 2025 Lifetime Achievement Award (Prof Jesús San-Miguel)

Young Hematologists in the Spotlight: EHA2025 Young EHA Award (Dr Mandy Lauw)

Supporting Hematology Innovation: Outcomes of an EHA Junior Research Grant (with Dr Ferran Nadeu Prat)

Ethical Considerations in Gene Therapy for Sickle Cell Disease and Thalassemia (with Prof Mariane de Montalembert)

Point-of-care Tests for Neonatal Screening of Sickle Cell Disease (with Prof Béatrice Gulbis)

What the EHA Burnout Survey Reveals for Hematologists (with Dr. Côme Bommier)

EHA2025 Diversity, Equity, and Inclusion Award: Prof Anna Schuh

A Successful Mentor’s Mindset: EHA2025 Education & Mentoring Award (Prof Jan Cools)

EHA Clinical Excellence Award 2025: Prof Khaled Musallam

Setting the Standard for Quality Care in Hematologic Malignancies (with Prof John Gribben)

Hematology Portraits: Prof Kirsten Grønbæk

Hematology Portraits: Prof Maria Domenica Cappellini

Gene Therapy Advances in SCD and B-Thalassemia (with Dr Stefano Rivella)

AML Management in the Old and Unfit (with Prof Hartmut Döhner)

Managing Young Fit AML patients with Prof Konstanze Döhner

GoCART Coalition (with Prof Christian Chabannon)

Empowering Healthcare through Patient Advocacy (with Jan Geissler)

Off-the-shelf CAR T-cells from iPSCs (with Prof Maria Themeli)

AIDPATH – AI automated CAR T-cell manufacturing (with Dr Carmen Sanges)

Hematology Portraits: prof. Elizabeth Macintyre

Is low-risk MDS really low risk? (with Prof Uwe Platzbecker)

MRD Monitoring in MDS Patients (with Prof Arjan van de Loosdrecht)

Hematology Portraits: prof. Martin Dreyling

MDS Pathophysiology and the Role of Immune Dysfunction (with Dr Shahram Kordasti)

Mapping Rare Anemia Patient Data: RADeep (with Dr. María del Mar Mañú Pereira)

Hematology Portraits: prof. Antonio Almeida

Targeting the Immune System in MDS (featuring Prof Dominik Wolf)

Accelerating Clinical Trials with AI (with Dr Jan Moritz Middeke)

The Current Diagnostic Approach to MDS (with Dr Onima Chowdhury)

Hematology Portraits: Prof Brian Huntly

Mental Health in CLL

Patient Perspectives on Gene Therapy for Sickle Cell Disease and B-Thalassemia

Hematology Portraits: Prof Kostas Stamatopoulos

Management of High-risk MDS: Seeking Clarity for Classification and Treatment

Hematopoietic Stem Cells in Health, Aging and Malignancy: Focus on Metabolism (EHA2024)

Innovative Trial Design (EHA2024)

Hereditary Hematological Malignancies (HHMs): A New Era of Discovery in MDS and AML (EHA2024)

Hairy Cell Leukemia (HCL): Treatment of Relapsed Disease (EHA2024)

Iron Metabolism in Myelodysplastic Syndrome (MDS)

First-line Treatment of Primary Central Nervous System Lymphoma (PCNSL) (EHA2024)

Optimizing Global Care for Women with von Willebrand Disease (VWD) (EHA2024)

Iron and Infections: Back to the Future (EHA2024)

Long-term Outcomes in the Chemo-free era for Acute Promyelocytic Leukemia (EHA2024)

Thrombotic thrombocytopenic purpura (TTP): Is plasmapheresis history?

The Role of Artificial Intelligence in Hematology (featuring Dr Gregor Hormann)

From MDS to AML: Genetics of Progression (featuring Prof Lars Bullinger)

Screening for Sickle Cell Disease (with Prof David Rees)

The Environmental Impact on Hematology Practice (with Dr Stephen Hibbs)

Synthetic Patients: The Future of Clinical Trials?

Innovative tools for Disease Monitoring in Multiple Myeloma

Hematology Portraits: Prof Ivo Touw

Preventing Venous Thromboembolism (VTE) in Pregnant Women

Gene Therapy for Hemophilia

AI-driven Morphology in Hematology

Regulatory Landscape for CAR T-cell Therapy

Point-of-care CAR T-cell Manufacturing

Processes in CAR T-cell Therapy

CAR T-cell Therapy for Children with ALL​

CAR T-cell Therapy in AML: State of the Art

Ethical Considerations in CAR T-cell Therapy

CAR T-cell Therapy - A Patient's Perspective

Developments in CAR T-cell Therapy

Precision Medicine in Myelodysplastic Syndromes (MDS)

Diversity, Equity, and Inclusion in Hematology

Trends in CAR T-cell Therapy

Precision Medicine in Chronic Lymphocytic Leukemia (CLL)

Precision Medicine in Rare Hematological Diseases: Pyruvate Kinase Activators

Precision Medicine in Follicular Lymphoma

Precision Medicine in Multiple Myeloma

Precision Medicine in Myeloproliferative Neoplasms

Precision Medicine and Clonal Hematopoiesis

Precision Medicine: Hepcidin Mimetics for Polycythemia Vera Treatment

Precision Medicine in Inherited Bone Marrow Failure Syndromes

The Whats in Scientific Publishing

The New Classification of Hemochromatosis: Why and How

Diversity, equity, and inclusion: Why this is important?

Unraveling Autoimmune Neutropenia: From Childhood to Adulthood

Navigating the World of Hematology Research: from Mentorship to Work-Life Balance

Myelodysplastic Syndrome (MDS) with Prof Kirsten Grønbæk

Immune cell therapies and targeted therapies in AML

Patient Communication and Self Care

Building prognostic models using big data with Prof Kimmo Porkka

Myeloma - Prof Jorge Sierra

Lymphoma - Dr Umut Yilmaz

How to Get Started in Hematology Research - Dr Anastasia Conti, Assoc Prof Maria Paola Martelli and Dr Simona Valletta

Pediatric Hematology - Dr Mirjam Belderbos

Iron metabolism: physiology and pathology

Pathogenesis and Management of Acute Chest Syndrome (ACS) in SCD

EHA Unplugged: MDS Classification and Risk Assessment

New Treatment of Iron Metabolism Defects: A Focus on Anemia of Inflammation

Latest Innovations and Future Perspectives in CAR-T Therapy

Current CAR-T Treatment for Lymphomas Focusing on DLBCL

Clinical Management of CAR-T Therapy in Myeloma

Challenges in receiving CAR-T treatment: Patient's perspective

Ph+ acute lymphoblastic lymphoma and the immune system in hematological neoplasms.

CAR-T Treatment in Myeloma: State of the Art

Reasons for Failure and Relapse and Mechanisms of Resistance in CAR-T

Economic Aspects of CAR-T: Challenges and Solutions

Update on CAR-T Therapies in Acute and Chronic Leukemias

Spotlight Talks: How I Treat Absolute Iron Deficiency in Inflammatory Disorders

Overview of the Current CAR-T Landscape

Papers Unplugged: Precision Medicine and Myeloid Neoplasms

Debate: Gene Addition or Gene Editing for Hemoglobinopathies?

What's in Store for Lymphoid Malignancies?

Spotlight Talks: Postpartum Hemorrhage (PPH)

Papers Unplugged: The Perspectives of Doctors and Patients in the Treatment of CLL

Papers Unplugged: Precision Medicine in AML

Debate: Should Low Risk PV-MF Patients be Treated?

Health Technology Assessment (HTA)

Spotlight Talks: New Agents for the Treatment of Thalassemia

Papers Unplugged: What's New in the Treatment of CLL?

Spotlight Talks: Updates on the Classification of Hematolymphoid Neoplasms—Myelodysplastic Syndromes

Papers Unplugged: TIF Guidelines for the Management of Patients with Transfusion-Dependent Thalassemia (TDT)

Spotlight Talks: Updates on the Classification of Hematolymphoid Neoplasms—Lymphoid Diseases

Papers Unplugged: Is CAR-T Economically Sustainable?

Papers Unplugged: What Ever Happened to Plan S?

Papers Unplugged: CHIP and Associated Risk in Elderly Patients

Papers Unplugged: EHA and War in Ukraine

Papers Unplugged: Precision Medicine and Hemoglobinopathies

Naive CLL

Thrombosis - Bleeding in Cancer

The Microbiome in HCT

Diagnosing Erythrocytosis

Clinical Trials of the Future (Clinical Trial)

Cutaneous T Cell Lymphoma (CTCL) Episode 1: Presentation and Diagnosis

Cutaneous T Cell Lymphoma (CTCL) Episode 2: Treatment

Circulating Tumor DNA

Treating CML in Developing Countries

Less is More - Transfusion

Chronic Myeloid Leukemia (Naomi)

All Good Things Must Come to an End: How and When to End a Clinical Trial (Clinical Trial)

Iron Deficiency: Perioperative

Documentation and authorization: Safeguarding the Credibility of Clinical Trials (Clinical Trial)

Ethical Issues Associated with Treating Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths)

Sponsor: A Role to Take Seriously (Clinical Trial)

Hematological Changes in Older Adults (Aging Patient: Dispelling Myths)

Patient Support: Relate and Create (Clinical Trial)

Treatment of Hematological Malignancies in Older Adults (Aging Patient: Dispelling Myths)

The Paper Trail (CRO) (Clinical Trial)

Patient Assessment In Older Adults (Aging Patient: Dispelling Myths)

Multiple Myeloma in Underserved Populations (Episode 3)

What matters in a trial design? (Clinical Trial)

Aging and Clonal Diseases (Aging Patient: Dispelling Myths)

Iron Deficiency: Women

Iron Deficiency: Chronic Kidney Disease

Iron Deficiency: Heart Failure

HSCT in Multiple Myeloma

Multiple Myeloma in Underserved Populations (Episode 2)

Chronic Lymphocytic Leukemia (CLL)

Chronic Myeloid Leukemia (CML)

SCD: What Physicians Can Learn From Patients And Carriers (Episode 3)

Multiple Myeloma in Underserved Populations (Episode 1)

SCD: What Physicians Can Learn From Patients And Carriers (Episode 2)

BCR-ABL1-like ALL

ALL Hope For The Future

Iron Homeostasis in Host Defense and Inflammation

SCD: What Physicians Can Learn From Patients And Carriers (Episode 1)

Impact of Social Stigma on Coping with SCD

Interventions in Adolescent SCD

Sickle Cell Disease in Pregnancy

HSCT in Paroxysmal Nocturnal Hemoglobinuria

HSCT in Severe Aplastic Anemia

Engraftment and Chimerism following HSCT

Infections in HSCT

Graft-versus-Host Disease in HSCT

The History of HSCT